If APAIC os is good ,perhaps ,that’ provides enough justification for the Merck board to offer IMM a huge outliscensing deal for the lag3 immunology platform.I don’t think Merck can afford not to do so.The longer they hold off the more they pay,it’s just a matter of both IMM and Merck agreeing on a price that both parties shareholders and boards feel comfortable with.It’s a win ,win
Media, page-69
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.010(3.57%) |
Mkt cap ! $421.8M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 29.0¢ | 27.5¢ | $814.3K | 2.871M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 186340 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 136417 | 6 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |